US$ 27.40
himiyer glp-1 Temu Glp1 Capsules Hims Inc. - Novo Nordisk's
Description
Tong is suing two online retailers, Florida-based 'Triggered Brands,' which sells vials of GLP-1 peptides

However, when companies blur the line from tailored, patient-specific compounding into mass production , they risk a, potentially company-ending, patent infringement lawsuit
When Wegovy and Zepbound vanished from retail shelves, your facility filled the void, providing semaglutide and tirzepatide to a desperate market

It's a safer investment from that point of view, in that it's not as risky as a pre-revenue pharma stock
